Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Kinesiology Taping in Duchenne Muscular Dystrophy: Effects on Performance, Gait Characteristics, and Energy Consumption

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03529240
Recruitment Status : Completed
First Posted : May 18, 2018
Last Update Posted : May 18, 2018
Sponsor:
Information provided by (Responsible Party):
Güllü AYDIN, Hacettepe University

Brief Summary:
Investigators investigated that the effects of kinesilogy taping on performance, energy consumption and gait characteristics in patients with Duchenne Muscular Dystrophy

Condition or disease Intervention/treatment Phase
Performance Energy Gait Duchenne Muscular Dystrophy Device: Kinesiology Taping Not Applicable

Detailed Description:
Forty-five patients from Level 1 and 2 according to the Brooke Lower Extremity Functional Classification were included in the study. Performance was assessed by measuring the distance in 6-minute walk test (6MWT) and the duration of timed performance tests; energy consumption by Physiological Consumption Index (PCI), and gait characteristics by footprint method on powdered ground at baseline. Kinesiology taping with facilitation technique was applied on bilateral quadriceps and tibialis anterior muscles and the assessments were repeated 1 hour after application. The comparison between before and after taping was analyzed.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 45 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Kinesiology Taping in Duchenne Muscular Dystrophy: Effects on Performance, Gait Characteristics, and Energy Consumption
Actual Study Start Date : June 10, 2017
Actual Primary Completion Date : August 5, 2017
Actual Study Completion Date : October 5, 2017


Arm Intervention/treatment
Experimental: Kinesiology taping
After performing the baseline assessments, kinesiology taping with facilitation technique was applied on bilateral quadriceps and tibialis anterior muscles of children. In both applications, the first and last 5 cm section of the bands were used as anchor and no tension was applied.
Device: Kinesiology Taping
Kinesiology taping (KT) which was developed by Dr. Kenzo Kase, is a new application of elastic and adhesive taping. KT is applied by specialized physiotherapists and physicians. This type of taping is a very frequently used technique to accelerate recovery after musculoskeletal injuries. Also, this technique is usually used as an alternative to athletic taping to support fascias, muscles, and joints for many purpose such as positioning, inhibition, and fascilitation




Primary Outcome Measures :
  1. Six Minute Walk Test [ Time Frame: 6 minute ]
    Six Minute Walk Test was used commonly in DMD were found to be valid, reliable and easy to apply in the clinic. Children were asked to walk during 6 minutes as fast as they can at a corridor specified by two cones and walking distances were recorded as meter (m) for 6MWT. The time passed during timed performance tests were recorded as seconds.


Secondary Outcome Measures :
  1. Energy Consumption [ Time Frame: 6 minutes ]
    Physiologic Consumption Index (PCI) was used to evaluate energy consumption of children during 6MWT. energy consumption was calculated by using the formula of PCI (walking heart rate)-(resting heart rate)/(walking speed)

  2. Gait [ Time Frame: 2 minutes ]
    Gait analysis of the children was performed by footprint method on 10-meters powdered floor. First and last 2 meters of this floor were dissociated from the assessment, and both the right and left stride lengths, both right and left foot angles, and stride width were analyzed in the middle 6-meter section.. Stride length was measured by measuring the distance between right and left midpoint heels. Double stride length was sum of right and left stride length. Stride width was measured by horizontal distance between heel midpoints. Foot angles were measured by a goniometer considering the line between the first and second metatarsal heads and the heel midpoints of both feet separately 24. The number of steps during 6MWT was also calculated by pedometer (Omron, Walking style One 2.0 HJ-320-E) and recorded.

  3. Timed Performance Test [ Time Frame: 10 minutes ]
    Ascending-descending standard 4 steps, walking 10m, standing from lying position were used in order to assess the performance of children.The time passed during timed performance tests were recorded as seconds.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   5 Years to 14 Years   (Child)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Duchenne Muscular Dystrophy diagnosis,
  • age 5 to 14 years,
  • able to cooperate with instructions of physiotherapist,
  • able to walk independently,
  • climb 4 steps independently/with minimal support from handrails.

Exclusion Criteria:

  • severe contracture at lower extremities,
  • other disease except for DMD, and
  • history of any injury or orthopaedic/neurologic surgery within the past 6 months.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03529240


Locations
Layout table for location information
Turkey
Hacettepe University
Ankara, Sıhhiye, Turkey, 06100
Sponsors and Collaborators
Hacettepe University
Investigators
Layout table for investigator information
Principal Investigator: Güllü Aydın, R.A Hacettepe University
Study Director: İpek Alemdaroğlu Gürbüz, Assoc. Prof. Hacettepe University
Principal Investigator: Öznur Yılmaz, Prof. Hacettepe University
Principal Investigator: Ayşe Karaduman, Prof. Hacettepe University
Principal Investigator: Numan Bulut, R.A Hacettepe University
Principal Investigator: Haluk Topaloğlu, Prof. Hacettepe University

Layout table for additonal information
Responsible Party: Güllü AYDIN, Research Assistant Güllü AYDIN, Hacettepe University
ClinicalTrials.gov Identifier: NCT03529240     History of Changes
Other Study ID Numbers: KA-17070
First Posted: May 18, 2018    Key Record Dates
Last Update Posted: May 18, 2018
Last Verified: May 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Güllü AYDIN, Hacettepe University:
kinesiology taping
performance
energy consumption
gait
Duchenne Muscular Dystrophy
Additional relevant MeSH terms:
Layout table for MeSH terms
Muscular Dystrophies
Muscular Dystrophy, Duchenne
Muscular Disorders, Atrophic
Muscular Diseases
Musculoskeletal Diseases
Neuromuscular Diseases
Nervous System Diseases
Genetic Diseases, Inborn
Genetic Diseases, X-Linked